Pregnancy

There are no formal comparative studies of ritonavir (Norvir) in pregnant women. However, animal studies and one study of ritonavir monotherapy in pregnant women suggest that the drug is relatively safe and effective, and that the risk of developmental abnormalities is low.1

References

  1. Lipongsaniurak S et al. Safety, tolerability and efficacy of ritonavir in the prevention of vertical transmission. Sixth Conference on Retroviruses and Opportunistic Infections, Chicago, abstract 241, 1999
This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.